Medicare billing address
CMS Medicare provider billing file
104 Pheasant Run Ste 128Newtown, PA 18940
CMS public data · NPI 1699764498
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Michael J Rozengarten, MD
Specialty
Credential
MD
NPI
1699764498
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Michael J Rozengarten, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
104 Pheasant Run Ste 128CMS Doctors & Clinicians file
104 Pheasant RunCMS Doctors & Clinicians file
3140 Princeton PikeIn the 2024 CMS provider billing file, this NPI had 1,132 Medicare beneficiaries and 6,285 total services. The average beneficiary age was 80, and the average HCC risk score was 1.8.
Total Medicare allowed amount
$370,068.34
Total Medicare payment amount
$282,629.54
Medicare beneficiaries
1,132
Total services
6,285
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Atrial fibrillation
75%
CMS beneficiary-panel share
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
58%
CMS beneficiary-panel share
Heart failure
41%
CMS beneficiary-panel share
Diabetes
37%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,965 | $29.52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 1,959 | $22.04 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 411 | $132.32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 408 | $14.66 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 389 | $16.72 |
| Programming of dual lead pacemaker system | 291 | $80.80 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 148 | $186.02 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 145 | $61.93 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 71 | $79.43 |
| Programming of multiple lead implantable defibrillator system | 70 | $107.54 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1699764498. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 328 | 564.5 | $319,167.06 |
| 2 | Metoprolol Succinate | Metoprolol Succinate | 231 | 631.9 | $5,109.72 |
| 3 | Dofetilide | Dofetilide | 160 | 427.2 | $27,094.74 |
| 4 | Metoprolol Tartrate | Metoprolol Tartrate | 121 | 291 | $663.55 |
| 5 | Diltiazem 24Hr Er (Cd) | Diltiazem Hcl | 111 | 249.6 | $3,179.10 |
| 6 | Flecainide Acetate | Flecainide Acetate | 94 | 202 | $4,378.40 |
| 7 | Amiodarone Hcl | Amiodarone Hcl | 52 | 138 | $1,801.50 |
| 8 | Xarelto | Rivaroxaban | 46 | 97 | $50,925.67 |
| 9 | Propafenone Hcl Er | Propafenone Hcl | 42 | 96 | $6,589.06 |
| 10 | Multaq | Dronedarone Hcl | 41 | 86 | $66,990.35 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
State University Of New York At Stony Brook, School Of Medicine
Graduation year
1997
Group/practice field
Capital Health Medical Group
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Cardiovascular Disease (Cardiology).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.